Abstract
This study investigated the effect of camel milk (CM) on blood coagulation in streptozotocin (STZ) – induced diabetic rats. Rats were split into four groups: controls, healthy rats treated with CM, STZ‐induced diabetic rats and diabetic rats treated with CM. The untreated diabetic animals showed marked hyperglycemia, significant hypofibrinogenemia and inhibition of platelet aggregation. CM treatment ameliorated hyperglycemia, blocked fibrinogen consumption and restored platelet aggregation. This antithrombotic action of CM offers further beneficial effects in addition to its known hypoglycemic action in diabetes. The responsible antithrombotic component(s) is a potential nutraceutical that needs further studies.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
